PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
29-Apr-2024 In situ Hybridization Market Expected to Reach USD 2.8 Billion by 2033 | Market.us Wired Release
29-Apr-2024 Brachytherapy Market Will Increase USD 2159.7 Million By 2033 And Has Guessed Around 8.2% CAGR Wired Release
29-Apr-2024 Hearing Protection Devices Market Estimated to Grow at 9.8% CAGR, Reaching USD 5,639 Million by 2033 Wired Release
29-Apr-2024 Biofungicides Market Size, To Witness Promising Growth Rate 15.8% by 2033 Wired Release
29-Apr-2024 ePharmacy Market Expansion: Anticipated To Reach USD 258.6 Billion By 2033 Wired Release
29-Apr-2024 Intrathecal Pumps Market to Expand at 5.4% CAGR, Reaching USD 611 Million by 2033 Wired Release
29-Apr-2024 Biobased Disinfectant Market Is Encouraged to Reach USD 8.7 Billion by 2033 at a CAGR of 7% Wired Release
29-Apr-2024 Pen Needles Market Projected To Reach USD 10.0 Billion By 2033, With CAGR Of 10.9% Wired Release
27-Apr-2024 Solstice Pacific Residential Treatment Center Awarded Behavioral Health Care and Human Services Accreditation From the Joint Commission AccessWire
26-Apr-2024 Asia Green Biotechnology Corp. Announces Delay in Filing of Annual Financial Statements and Application for Management Cease Trade Order AccessWire
26-Apr-2024 RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting AccessWire
26-Apr-2024 RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting Relief Therapeutics Holding SA
26-Apr-2024 PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency Newswire
26-Apr-2024 PharmaLink Inc. and Recall Results, Inc. Announce Strategic Partnership to Enhance Drug Safety and Recall Efficiency AccessWire
26-Apr-2024 ARAMEX SCOOPS ACCOLADE AT DISTRIBUTING PHARMACEUTICALS AWARDS Aramex
26-Apr-2024 CompendiRx Unveils Innovative Approach to Long COVID: Empowering Patients Worldwide AccessWire
26-Apr-2024 Stockholm, Sweden – April 26 2024 – OncoZenge AB (publ), a leading pharmaceutical company developing BupiZenge™, an innovative, non-opioid treatment for oral pain, today announces the appointment of Anna Asplind as Phase 3 Program Manager. OncoZenge
26-Apr-2024 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda HUTCHMED
26-Apr-2024 Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity AccessWire
26-Apr-2024 Swedencare launches NaturVet by Swedencare: Bringing America’s leading pet brand to Europe Swedencare